The Effects of Melatonin Administration on Bone Tissue SIRT1 levels in old Female Rats with Diabetic

References

1. C. Zhao, G. Liu, Y. Zhang, G. Xu, X. Yi, J. Liang, Y. Yang, J. Liang, C. Ma , Y. Ye, M. Yu, and Qu X, “Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus,” J Clin Lab Anal, 2019, e23112.
2. C.E. Murray and C.M. Coleman, “Impact of Diabetes Mellitus on Bone Health,” Int J Mol Sci, 2019, 20(19), pii. E4873.
3. M. Bicer, S.B. Baltaci, S. Patlar, R. Mogulkoc and A.K. Baltaci, “Melatonin has a protective effect against lipid peroxidation in the bone tissue of diabetic rats subjected to acute swimming exercise,” Horm Mol Biol Clin Investig, 2018, 34(2), pii. /j/hmbci.2018.34.issue-2.
4. S. Yildirimturk, S. Batu, C. Alatli, V. Olgac, D. Firat and Y. Sirin, “The effects of supplemental melatonin administration on the healing of bone defects in streptozotocin-induced diabetic rats,” J Appl Oral Sci, 2016, 24(3):239-249.
5. W.L. Zhang, H.Z. Meng, R.F. Yang, M.W. Yang, G.H. Sun, J.H. Liu, P.X. Shi, F. Liu and B. Yang, “Melatonin suppresses autophagy in type 2 diabetic osteoporosis” Oncotarget, 2016, 7(32), 52179-52194.
6. W.X. Zhang, B.M. He, Y. Wu, J.F. Qiao and Z.Y. Peng, “Melatonin protects against sepsis-induced cardiac dysfunction by regulating apoptosis and autophagy via activation of SIRT1 in mice,” Life Sci, 2019,217:8-15.
7. S.W. Lai, Y.S. Liu, D.Y. Lu and C.F. Tsai, “Melatonin Modulates the Microenvironment of Glioblastoma Multiforme by Targeting Sirtuin 1,” Nutrients, 2019, 11(6), pii. E1343.

Cited by

0 — Crossref — cited-by count (retrieved 2 Oct 2026, source)

Citation counts are shown with their source and retrieval date. They are not an Impact Factor or any journal-level metric.